Seres Therapeutics CEO: Banking On Bacteria | Mad Money | CNBC
Seres Therapeutics CEO: Banking On Bacteria | Mad Money | CNBC
This biotech tripled in its June IPO, but it’s been a rollercoaster ever since. Is it time to buy? » Subscribe to CNBC: http://cnb.cx/SubscribeCNBC » Watch more …
source
Comments